Positron emission tomography studies in movement disorders. (Q41718477)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Positron emission tomography studies in movement disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495890%20AND%20SRC:MED&resulttype=core&format=json

positron emission tomography

9 November 2019

main subject

1 reference

Brooks DJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495890%20AND%20SRC:MED&resulttype=core&format=json

Neurosurgery clinics of North America

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

263-282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495890%20AND%20SRC:MED&resulttype=core&format=json

Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal binding of 11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Disturbance of sequential movements in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The behavioural and motor consequences of focal lesions of the basal ganglia in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomography in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal dopamine D2 receptors in tardive dyskinesia: PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Stereotactic thalamotomy in tremor-dominant Parkinson's disease: an H2(15)O PET motor activation study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Motor reorganization in acquired hemidystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

THE BEREITSCHAFTSPOTENTIAL IS ABNORMAL IN PARKINSON'S DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Stereotactic ventral pallidotomy for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Regional brain glucose metabolism in neuroacanthocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The metabolic topography of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The metabolic topography of idiopathic torsion dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatonigral degeneration. A clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

A genetic study of idiopathic torsion dystonia in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The relationship between global and local changes in PET scans

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The neostriatal mosaic: multiple levels of compartmental organization

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomography in the early diagnosis of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Studies in persons at risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomography measures of benzodiazepine receptors in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Brain neurotransmitters in dystonia musculorum deformans

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomography in cases of chorea with different underlying diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Progressive supranuclear palsy: clinical features and response to treatment in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Self-initiated versus externally triggered movements

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Brain neurotransmitters in dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Normal striatal glucose consumption in two patients with benign hereditary chorea as measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Correlative neuroanatomical and neuropharmacological study of tremor and catatonia in the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Executive and mnemonic functions in early Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The anatomical basis of symptomatic hemidystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Clinical and [18F] dopa PET findings in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal dopamine distribution in parkinsonian patients during life

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Human gene for torsion dystonia located on chromosome 9q32-q34.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Evidence for a common network of brain structures involved in parkinsonian tremor and voluntary repetitive movement

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal inhomogeneities and basal ganglia function

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Regional blood flow in hemiparkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Dopaminergic function in familial Parkinson's disease: A clinical and18F-dopa positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal (18F)dopa uptake in familial idiopathic dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal amines, experimental tremor and the effect of harmaline in the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Multiple system atrophy--the nature of the beast

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

A Two-Compartment Description and Kinetic Procedure for Measuring Regional Cerebral [11C]Nomifensine Uptake Using Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Dopa-responsive dystonia: [18F]dopa positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Neurophysiological properties of pallidal neurons in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

PET studies of cerebral glucose metabolism in idiopathic torticollis

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Cerebral metabolism of glucose in benign hereditary chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Abnormal vibration-induced cerebral blood flow responses in idiopathic dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Abnormal cortical responses in patients with writer's cramp

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas A PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

A 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Cortical control of movement in Huntington's disease. A PET activation study

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Increased striatal glucose consumption in Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

Normal caudate glucose metabolism in persons at risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline

1 reference

https://api.crossref.org/works/10.1016%2FS1042-3680%2818%2930263-8

7 January 2021

10.1016/S1042-3680(18)30263-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference